Siyuan (Katherine) Liu

• Conduct secondary and primary research on therapeutic areas in which Baheal has invested and may consider for future investments. • Participate in healthcare conferences in the United States to gather information, generate insights, and provide updates to the internal team.

• Conducted primary research by interviewing over 20 healthcare providers and payers, along with secondary research for a major pharmaceutical company to assess the market access of biosimilars for two blockbuster oncology drugs in both the U.S. and EU markets • Developed a pricing framework for a pharmaceutical company launching its first drug in the United States • Pioneered a value-based contract playbook for the global multiple myeloma market, creating an Excel model to simulate potential outcomes and facilitating three successful rollouts for seamless implementation for clients • Evaluated cold-chain distribution business on a global scale, providing 5- and 10-year forecasts for a private equity firm • Created Miro boards and facilitated in-person workshops with Amgen for its internal projects

• Led a team of four to provide strategic support for management consultancy in the areas of forecasting, strategic planning, digital marketing, and portfolio management with a focus on pharmaceutical, medical care, biotechnology, and property companies, ensuring timely delivery of three strategic projects • Interviewed three executives, seven industry experts, and four practicing physicians to develop insights and a differentiated analysis on technical and market uncertainties, key success factors, and risk / reward payoffs when rolling out new drug pipeline

• Managed the analysis of oncology accounts of NCCN Designated Cancer Centers, recognized major working mechanism gaps, and proposed solutions to senior management to increase customer value and internal efficiency by 25% • Investigated and analyzed 100+ research papers and financial statements to construct Key Account Dossiers for 31 NCCN Cancer Centers, identified $150M+ annual revenue opportunity, and presented to department Director, leading to the creation of dedicated sales team to support growing market segments and further discussion on potential transformation models • Prepared a bi-weekly newsletter to communicate team initiatives and pipeline development to senior management

• Managed a cross-functional team in performing life science industry analysis including products, suppliers, customers, and competitive landscape, and sent weekly report for management team review, facilitating better decision-making • Conducted detailed analysis on top players in the US and China in the life science industry and major renovations, built financial models, performed scenario analysis, and evaluated investment attractiveness of several target companies, resulting in further M&A discussion meetings with those companies

• Served as department head’s right-hand man for the entire business operation and bridged to 10+ business unit product managers • Facilitated bi-weekly meetings between key stakeholders in China and the global team on latest clinical and policy development in China, enhancing transparency and ensuring clear communication • Launched a corporate online training platform to help employees learn about corporate culture, operation processes, and internal systems, increasing employee engagement rate by 30% and new hires satisfaction by 55%

• Conducted in-depth research on potential disasters risk mitigation by analyzing 10+ research papers and interviewing 20+ industry experts and developed an algorithm for clinical risk mitigation playbook, increasing accuracy and efficiency by 35% • Analyzed Amgen’s Master Study List (MSL) to identify the probability of molecules’ success in different phased clinical trials and created a Python script to automate the parsing of MSL data, saving time and minimizing data transcription errors • Devised marketing strategy for four early-stage anti-cancer drugs worth $5B+ by collaborating with cross-functional teams • Visualized 500+ data points on Tableau to generate three playbooks to test and refine algorithm, improving operational efficiency

• Led outreach to 100+ Venture Capital firms for funding for Nammi and the creation of pitch materials, including financial forecasts and strategic considerations, and coordinated negotiation process between senior management and Venture Capital firms • Evaluated partnership opportunities with eight pharmaceutical companies, performed due diligence and risk analysis, resulting in further discussion on oncology product development and commercialization potential

• Prepared and submitted bio-informatic materials, stakeholders financial documents, and Vazyme’s policies to Securities Regulatory Commission and pushed Vazyme’s initial public offering • Collaborated with sponsor institutions, accounting firms, asset appraisal agencies, law firms and other intermediary agencies to cowrite the restructuring plan of the company and submitted to Shanghai Stock Exchange to finalize the company’s listing

• Reached out to Pitzer alumni and family members, and raised about 2,500 US dollars in funds • Kept alumni and family members’ information up to date, talked about Pitzer stories and shared ways to support the institution

Pursuing a combine major of Science and Management and Psychology.

Attended one-month Spanish intense program in June 2018.